One Pandemic, Two Solutions: Comparing the U.S.-China Response and Health Priorities to COVID-19 from the Perspective of “Two Types of Control”

Author:

Lyu Shupeng1,Qian Chen1,McIntyre Aaron1,Lee Ching-Hung1

Affiliation:

1. School of Public Policy and Administration, Xi’an Jiaotong University, Xi’an 710049, China

Abstract

After three years of global rampage, the COVID-19 epidemic, the most serious infectious disease to occur worldwide since the 1918 influenza pandemic, is nearing its end. From the global experience, medical control and social control are the two main dimensions in the prevention and control of COVID-19. From the perspective of “two types of control”, namely medical control and social control, this paper finds that the political system, economic structure, and cultural values of the United States greatly limit the government’s ability to impose social control, forcing it to adopt medical control to fight the virus in a single dimension. In contrast, China’s political system, economic structure, and cultural values allow its government to adopt stringent, extensive, and frequent social control, as well as medical control to fight the virus. This approach departs from the traditional pathway of fighting the epidemic, i.e., “infection–treatment–immunization”, thereby outpacing the evolution of the virus and controlling its spread more rapidly. This finding helps explain why the Chinese government adopted a strict “zeroing” and “dynamic zeroing” policy during the first three years, at the cost of enormous economic, social, and even political legitimacy. It was not until late 2022, when the Omicron variant with the waning virulence became prevalent, that China chose to “coexist” with the virus, thus avoiding a massive epidemic-related death. While the United States adopted a pulsed-style strategy at the beginning of the epidemic, i.e., “relaxation–suppression–relaxation–suppression”, and began to “coexist” with the virus in just one year, resulting in a large number of excess deaths associated with the epidemic. The study contributes to explaining the difference in the interplay between public health priorities and COVID-19 response strategies in China and the United States, based on the specific public health context and the perspective of “medical control” and “social control”.

Funder

National Social Science Fund of China

Innovation Capacity Support Project of Shaanxi Province

National Natural Science Foundation of China

Publisher

MDPI AG

Subject

Health Information Management,Health Informatics,Health Policy,Leadership and Management

Reference87 articles.

1. World Health Organization (2023, May 11). Available online: https://covid19.who.int/data.

2. World Health Organization (2022, November 15). Available online: https://www.who.int/data/stories/global-excess-deaths-associated-with-covid-19-january-2020-december-2021/.

3. Mobilizing policy (in)capacity to fight COVID-19: Understanding variations in state responses;Capano;Policy Soc.,2020

4. Wasnik, R.N., Vincze, F., Foldvari, A., Palinkas, A., and Sandor, J. (2023). Effectiveness of and Inequalities in COVID-19 Epidemic Control Strategies in Hungary: A Nationwide Cross-Sectional Study. Healthcare, 11.

5. China’s public health policies in response to COVID-19: From an “authoritarian” perspective;Gao;Front. Public Health,2021

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3